BAKER BROS. ADVISORS LP

Position in JBIO — Jade Biosciences, Inc.

CIK 1263508 NEW YORK, NY

Position in JBIO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$27,340,065

+$4,282,091 QoQ

Shares Held

1,230,426

-25.0% QoQ

Ownership

1.93%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#18

of 153 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. JBIO ranks #43 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	30,762,330	$3,487,217,728
2	ONC	BeOne Medicines Ltd.	8,801,567	$2,508,182,547
3	RVMD	Revolution Medicines, Inc.	11,443,357	$2,143,111,898
4	MDGL	Madrigal Pharmaceuticals, Inc.	2,143,131	$1,150,754,190
5	ACAD	Acadia Pharmaceuticals Inc	42,912,904	$1,085,696,471
6	KYMR	Kymera Therapeutics, Inc.	8,657,242	$992,725,940
7	INSM	INSMED Inc	8,796,111	$937,841,354
8	CELC	Celcuity Inc.	7,915,792	$828,150,159

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,340,065	1,230,426	-25.0%	Shares	Sole	2026-08-14
2026-03-31	$23,057,974	1,641,137	0.0%	Shares	Sole	2026-05-15
2025-12-31	$25,322,743	1,641,137	—	Shares	Sole	2026-02-17
2023-03-31 AVTE	—	1,963,479	-0.7%	Shares	Sole	2023-05-15
2022-12-31 AVTE	—	1,976,868	-0.1%	Shares	Sole	2023-02-14
2022-09-30 AVTE	—	1,979,568	-4.4%	Shares	Sole	2022-11-14
2022-06-30 AVTE	—	2,070,010	0.0%	Shares	Sole	2022-08-15
2022-03-31 AVTE	—	2,070,010	+13.0%	Shares	Sole	2022-05-16
2021-12-31 AVTE	—	1,831,789	+10.9%	Shares	Sole	2022-02-14
2021-09-30 AVTE	—	1,652,171	+15.7%	Shares	Sole	2021-11-15
2021-06-30 AVTE	—	1,428,571	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.